Antimicrobial drug resistance in Singapore hospitals

被引：72

作者：

Hsu, Li-Yang ^{[1
]}

Tan, Thean-Yen

Jureen, Roland

Koh, Tse-Hsien

Krishnan, Prabha

Lin, Raymond Tzer-Pin

Tee, Nancy Wen-Sin

Tambyah, Paul Ananth

机构：

[1] Natl Univ Singapore, Singapore 117548, Singapore

[2] Changi Gen Hosp, Singapore, Singapore

[3] Alexandra Hosp, Singapore, Singapore

[4] Singapore Gen Hosp, Singapore 0316, Singapore

[5] Tan Tong Seng Hosp, Singapore, Singapore

[6] KK Womens & Childrens Hosp, Singapore, Singapore

来源：

EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 12期

关键词：

D O I：

10.3201/eid1312.070299

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A new national antimicrobial resistance surveillance program in Singapore public hospitals that uses WHO-NET detected high levels of methicillin resistance among Staphylococcus aureus (35.3%), carbapenem resistance among Acinetobacter spp. (49.6%), and third-generation cephalosporin resistance among Klebsiella pneumoniae (35.9%) hospital isolates in 2006. Antimicrobial drug resistance is a major problem in Singapore.

引用

页码：1944 / 1947

页数：4

共 9 条

[1]

BELL SM, 2005, ANTIBIOTIC SUSCEPTIB

[2]

*CLIN LAB STAND I, 2005, PERF STAND ANT SUSC, V24

[3]

*CLIN LAB STAND I, 2006, AN PRES CUM SUSC TES, V25

[4] Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002) [J].

Hirakata, Y ;

Matsuda, J ;

Miyazaki, Y ;

Kamihira, S ;

Kawakami, S ;

Miyazawa, Y ;

Ono, Y ;

Nakazaki, N ;

Hirata, Y ;

Inoue, M ;

Turnidge, JD ;

Bell, JM ;

Jones, RN ;

Kohno, S .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (04) :323-329

[5] IMP-4 and OXA β-lactamases in Acinetobacter baumannii from Singapore [J].

Koh, Tse Hsien ;

Sng, Li-Hwei ;

Wang, Grace Chee Yeng ;

Hsu, Li-Yang ;

Zhao, Yi .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) :627-632

[6]

Simonsen GS, 2004, B WORLD HEALTH ORGAN, V82, P928

[7] Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin [J].

Song, JH ;

Hiramatsu, K ;

Suh, JY ;

Ko, KS ;

Ito, T ;

Kapi, M ;

Kiem, S ;

Kim, YS ;

Won, SH ;

Peck, KR ;

Lee, NY .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4926-4928

[8] Trends in antimicrobial drug development: Implications for the future [J].

Spellberg, B ;

Powers, JH ;

Brass, EP ;

Miller, LG ;

Edwards, JE .

CLINICAL INFECTIOUS DISEASES, 2004, 38 (09) :1279-1286

[9]

Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819

← 1 →